Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With Coronavirus Disease-19

Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With Coronavirus Disease-19

IntroductionThe impact of colchicine on hospitalized patients with Coronavirus disease-19 (COVID-19) related cardiac injury is unknown.Materials and MethodsIn this multicenter randomized controlled open-label clinical trial, we randomized hospitalized adult patients with documented COVID-19 and evid...

Full description

Bibliographic Details
Main Authors: Amir Rabbani, Asim Rafique, Xiaoyan Wang, Danielle Campbell, Daniel Wang, Nicholas Brownell, Kenia Capdevilla, Victoria Garabedian, Sandra Chaparro, Raul Herrera, Rushi V. Parikh, Reza Ardehali
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
COVID-19
colchicine
cardiac injury
myocarditis
inflammasome
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.876718/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.876718/full

Similar Items